EPISODE 19: Cherie Dear – Grief, Agency, and Daring to Hope

EPISODE 19: Cherie Dear – Grief, Agency, and Daring to Hope

EPISODE DESCRIPTION: What does it take to rebuild life, purpose, and meaning after unimaginable loss?

In this poignant episode of Recalibrating with Sharee Johnson, we hear from Cherie Dear, Founder and CEO of Dare to Hope, a charity driving pancreatic cancer research in Australia. Cherie shares her lived experience of facing the terminal diagnosis and death of her husband, AFL footballer Paul Dear, and how she is meeting her grief with action that creates hope. A deeply human conversation on agency, community, conscious choices, difficult conversations and why hope is so much more than wishful thinking.

SHOW NOTES “You have two choices in life. You can take things on pessimistically or you can be optimistic… Hope is a strategy.” — Cherie Dear

Key Takeaways: Grief and loss can draw clarity to what truly matters, stripping away the noise and prompting recalibration. Agency is essential; taking proactive steps, seeking information, and becoming assertive can make a difference in a healthcare journey. Community and support networks provide both practical help and emotional fortitude—sometimes in creative, non-intrusive ways. Choosing hope is an act of courage and conscious thought, not denial or naivety. Contribution and connection—through volunteerism, shared stories, and advocacy—can offer healing and renewed purpose.

Resources & References: Dare to Hope Foundation: Find out more, get involved, or make a donation at Dare to Hope's website.

Watch the Dear Family Documentary: Cherie Dear and her family’s journey through diagnosis, loss, and advocacy. -Available to stream now exclusively on SBS on Demand and Kayo.

Melbourne Integrative Oncology Group: Where complementary therapies supported Paul’s care. Garvan Institute & Peter MacCallum Cancer Centre: Recipients of Dare to Hope research fellowships advancing pancreatic cancer science.

Omico: For information on genomic profiling and cancer clinical trials: Omico website.

ASCO: Updates on new developments, including the Daraxonrasib clinical trial for pancreatic cancer. https://www.asco.org/about-asco/press-center/multi-selective-ras-inhibitor-nearly-doubles-survival-pancreatic-cancer

Mentioned Concepts: Recalibrating through adversity: shifting identities, roles, and mindsets. The importance of agency, realism, and surrender at the right time—preparing for a “good death.” The difference between wishful thinking and actionable, strategic hope. The significance of naming, ritual, and community recognition in the grieving process—like the Dare to Hope Field of Silhouettes at the MCG.

Our theme music is "Caribbean" by Zambolino, sourced from FreeToUse.com/music/zambolino/caribbean.

Disclaimer: The content in this podcast is not intended as a substitute for professional medical or psychological advice. Always seek advice from your doctor or qualified healthcare professional. The views expressed are those of the hosts and guests and do not necessarily represent any entity they work with or for.

Connect and Subscribe: Enjoyed this conversation? Please subscribe, leave a review, and share with colleagues or friends who may benefit from stories of recalibration and growth in healthcare. Stay tuned for future episodes with inspiring guests!